Advertisement

Topics

Evofem Plans 2019 Refiling For Amphora Based On New 86% Contraception Efficacy

10:11 EST 18 Dec 2018 | SCRIP

Evofem intends to refile the NDA for its non-hormonal contraceptive Amphora during the second quarter of 2019, after the Phase...

      

Related Stories

 

Original Article: Evofem Plans 2019 Refiling For Amphora Based On New 86% Contraception Efficacy

NEXT ARTICLE

More From BioPortfolio on "Evofem Plans 2019 Refiling For Amphora Based On New 86% Contraception Efficacy"

Advertisement
Quick Search
Advertisement
Advertisement